Work

A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma

Year: 2020

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-19-1899

Authors: James R. Berenson, Jennifer To, Tanya M. Spektor, Daisy Martinez, Carley Turner, Armando Sanchez, Matthew Ghermezi, Benjamin M. Eades, Regina A. Swift, Gary Schwartz, Shahrooz Eshaghian, Laura Stampleman, Robert A. Moss, Stephen Lim, Robert Vescio

Institutions: Oncotherapeutics (United States), Institute for Myeloma & Bone Cancer Research, Cedars-Sinai Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2999468559

FWCI: 4.42

Cites: 34

Cited by: 36

Related to: 10